MedImpact Expands Portfolio of Health Solutions with Acquisition of Two Employer Insurance and Risk Management Companies
MedImpact Holdings, Inc., the nation’s largest independent health solutions and pharmacy benefit company, today announced the acquisition of two innovative risk management firms: MHW Benefit Partners (formerly SRS Benefit Partners) and MSL Captive Solutions.
MedImpact Offers Humira Biosimilar 95% Below the Cost of Humira to Any Hospital or Pharmacy
MedImpact Holdings, Inc. today announced the launch of an unbranded biosimilar to Humira® (adalimumab) priced at 95% below the brand-name cost. MedImpact is offering this biosimilar (adalimumab-ryvk), manufactured by Anda, an affiliate of Teva Pharmaceuticals USA, Inc., through its preferred partner, Birdi Inc., to any hospital, plan, or pharmacy nationwide—not just its own clients or affiliates.
